Patents by Inventor Alejandro Alagon

Alejandro Alagon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plasminogen activator from saliva of the vampire bat
    Patent number: 6008019
    Abstract: The present invention relates to novel thrombolitic v-PA's which dissolve blood clots in the human body and thus are suitable for the treatment of cardial infarction, for example.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: December 28, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Berthold Baldus, Peter Donner, Wolf-Dieter Schleuning, Alejandro Alagon, Werner Boidol, Jorn Reiner Kratzschmar, Bernard Jacques Haendler, Gernot Langer
  • Thrombin inhibitor from the saliva of protostomia
    Patent number: 5876971
    Abstract: The invention relates to a natural protein or a protein that can be synthetically produced, which is a thrombin inhibitor and can be isolated from the saliva of insects which suck the blood of mammals. Preferred is the Triatoma pallidipennis insect. The protein is used for the treatment of thromboses or unstable angina or arteriosclerosis, or for the prevention of a reblockage of vessels after PTCA/PTA or for the prevention of blood clotting in hemodialysis.
    Type: Grant
    Filed: August 24, 1995
    Date of Patent: March 2, 1999
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguierre, Peter Donner, Bernard Haendler, Ulrike Hechler
  • Collagen-induced platelet aggregation inhibitor
    Patent number: 5756454
    Abstract: The invention provides a protein which inhibits collagen-induced platelet aggregation, derived from Triatoma pallidipennis, and derivatives thereof. The protein is useful for inhibition of collagen-induced human platelet aggregation or of cancer with metastatic tumor cells.
    Type: Grant
    Filed: March 7, 1994
    Date of Patent: May 26, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Bernard Haendler, Joern Reiner Kraetzschmar, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguirre
  • Collagen-induced platelet aggregation inhibitor
    Patent number: 5723312
    Abstract: The invention provides a protein which inhibits collagen-induced platelet aggregation, derived from Triatoma pallidipennis, and derivatives thereof. The protein is useful for inhibition of collagen-induced human platelet aggregation or of cancer with metastatic tumor cells.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 3, 1998
    Assignee: Schering Aktiengesellschaft
    Inventors: Christiane Noeske-Jungblut, Bernard Haendler, Joern Reiner Kraetzschmar, Wolf-Dieter Schleuning, Alejandro Alagon, Lourival Possani, Delia Cuevas-Aguirre